Loading insider details...
Beta
Latest Form 4 (Oct 1, 2026): Exercise/Conversion of 6,000 RVMD shares, $353.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Revolution Medicines, Inc. (RVMD) | Exercise/Conversion | 6,000 | $353.0K |
| Sep 18, 2026 | Revolution Medicines, Inc. (RVMD) | Sale | 5 | $974.79 |
| Jan 21, 2026 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 10,100 | n/a |
| Apr 15, 2025 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 125,000 | n/a |
| Jan 23, 2025 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 100,000 | n/a |
| Nov 19, 2024 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 600,000 | n/a |
| Aug 7, 2024 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 40,400 | n/a |
| Jun 17, 2024 | Elevation Oncology, Inc. (ELEV) | Grant/Award | 35,000 | n/a |
| Mar 4, 2024 | Elevation Oncology, Inc. (ELEV) | Grant/Award | 55,000 | n/a |
| Jan 23, 2024 | Mirati Therapeutics, Inc. (MRTX) | Disposition to Issuer | 10,547 | n/a |